scalded skin syndrome

scalded skin syndrome. It is a blistering skin condition caused by a toxin-producing strain of the bacterium Staphylococcus aureus. Primarily affecting infants, young children, and immunocompromised adults, the disease is characterized by widespread redness and peeling of the skin, resembling a severe burn. Prompt diagnosis and treatment with intravenous antibiotics are critical to prevent serious complications such as sepsis and fluid imbalance.

Signs and symptoms

The initial prodromal phase often includes nonspecific symptoms like fever, irritability, and skin tenderness. A diffuse, scarlet fever-like erythema typically appears, often beginning around the mouth and flexor creases before spreading. Within 24 to 48 hours, characteristic superficial blisters form that rupture easily, leading to widespread exfoliation where large sheets of skin peel off, leaving a moist, red base resembling a scald. The Nikolsky sign is positive, where gentle rubbing of the skin causes peeling. Mucous membranes, such as those in the conjunctiva and oral mucosa, are usually not involved, which helps distinguish it from other severe blistering disorders.

Causes

The disorder is caused by specific strains of Staphylococcus aureus that produce exfoliative toxins, primarily ETA and ETB. These toxin-producing bacteria often colonize minor sites of infection such as the umbilicus in neonates, the nasopharynx, conjunctiva, or a superficial cutaneous abscess. The condition is not caused by direct bacterial invasion of the skin but by the systemic circulation of these toxins. Outbreaks have been documented in settings like hospital nurseries and neonatal intensive care units, where the bacterium can spread between susceptible individuals.

Pathophysiology

The exfoliative toxins produced by Staphylococcus aureus act as serine proteases. Their specific target is desmoglein-1, a cadherin protein essential for cell-to-cell adhesion within the upper layers of the epidermis, specifically the stratum granulosum. By cleaving this protein, the toxins cause a loss of adhesion between keratinocytes, resulting in intraepidermal splitting. This leads to the formation of fragile blisters and the widespread sloughing of skin. The split occurs superficially, sparing the deeper dermis and mucous membranes, which express different desmoglein isoforms.

Diagnosis

Diagnosis is primarily clinical, based on the characteristic rash and presentation in a susceptible age group. Confirmation can involve isolating Staphylococcus aureus from a potential primary site of infection, such as the nasopharynx, conjunctiva, or blood. A skin biopsy sent for frozen section analysis can show the characteristic intraepidermal cleavage plane, which is more superficial than that seen in conditions like toxic epidermal necrolysis. Differentiating it from other blistering diseases, such as toxic epidermal necrolysis (often drug-induced) or Kawasaki disease, is crucial for appropriate management.

Treatment

Immediate hospitalization is required. Treatment centers on eradicating the source of toxin with intravenous antibiotics effective against Staphylococcus aureus, such as penicillinase-resistant penicillins (e.g., flucloxacillin, nafcillin) or cephalosporins like cefazolin. In areas with a high prevalence of MRSA, agents like vancomycin or clindamycin are used. Supportive care is paramount and includes meticulous wound care akin to that for burn patients, fluid and electrolyte replacement, temperature regulation, and pain management. Use of intravenous immunoglobulin has been reported in severe cases.

Prognosis

With prompt and appropriate treatment, the prognosis is generally excellent. The skin typically heals without scarring within 5 to 7 days after antibiotic therapy is initiated, as the damage is confined to the superficial epidermis. Mortality is low in otherwise healthy children but increases significantly in adults, particularly those with underlying comorbidities such as chronic kidney disease or immunosuppression. Complications, though rare, can include cellulitis, pneumonia, septic shock, and significant fluid loss leading to hypovolemia. Category:Dermatology Category:Bacterial diseases Category:Pediatrics